氮卓斯汀鼻喷剂抑制过敏性鼻炎患者人鼻黏膜交感神经功能
本研究在体外直接观察氮卓斯汀对过敏性鼻炎患者离体人鼻黏膜的作用,发现10⁻⁶ M及以上浓度的氮卓斯汀对10⁻⁶ M甲氧明诱导的黏膜收缩产生显著舒张反应,并可抑制电场刺激诱导的黏膜收缩尖峰,且浓度增加对鼻黏膜基础张力影响极小。作者认为氮卓斯汀鼻喷剂虽常用于改善过敏性鼻炎症状,但因抗交感作用,鼻塞可能不会立即缓解。
要点
- 氮卓斯汀对10⁻⁶ M甲氧明诱导的鼻黏膜收缩产生显著舒张反应,最低有效浓度为10⁻⁶ M。
- 氮卓斯汀可抑制电场刺激诱导的鼻黏膜收缩尖峰。
- 氮卓斯汀浓度增加对鼻黏膜基础张力影响极小,但鼻塞可能不会立即缓解。
核心结论
- 氮卓斯汀在体外可抑制电场刺激和甲氧明诱导的鼻黏膜收缩;尽管氮卓斯汀鼻喷剂常用于改善过敏性鼻炎症状,但因抗交感作用,鼻塞可能不会立即缓解。
研究设计与样本
- 体外研究:采用过敏性鼻炎患者的离体人鼻黏膜,检测氮卓斯汀对黏膜静息张力、10⁻⁶ M甲氧明(拟交感药)所致收缩及电诱导黏膜收缩的影响。
主要发现
- 向孵育液中加入甲氧明可使鼻黏膜呈剂量依赖性收缩。
- 加入10⁻⁶ M或以上浓度的氮卓斯汀对10⁻⁶ M甲氧明诱导的黏膜收缩产生显著舒张反应。
- 氮卓斯汀可抑制电场刺激诱导的黏膜收缩尖峰。
- 增加氮卓斯汀浓度对鼻黏膜基础张力影响极小。
临床怎么用
- 作者认为,尽管氮卓斯汀鼻喷剂常用于治疗过敏性鼻炎以改善症状,但因氮卓斯汀的抗交感作用,鼻塞可能不会立即缓解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Azelastine hydrochloride (azelastine) nasal spray is a histamine receptor-1 (H1) antagonist often used in treating allergic rhinitis to relieve its symptoms. However, the effects of azelastine to influence decongestion on human nasal mucosa in patients with allergic rhinitis are not yet fully explored and merit further exploration. The effects of azelastine on the vasocontractile responses generated by smooth muscles in the vascular structures of human nasal mucosa were investigated directly in vitro. METHODS: We examined the effectiveness of azelastine on isolated human nasal mucosa by testing: 1) the effect on mucosa resting tension; 2) the effect on mucosal contraction caused by 10-6 M methoxamine as a sympathetic mimetic; 3) the effect of the drugs on electrically induced mucosal contractions. RESULTS: The results indicated that addition of methoxamine to the incubation medium caused the nasal mucosa to contract in a dose-dependent manner. Addition of azelastine at doses of 10â€"6 M or above elicited a significant dilation response to 10â€"6 M methoxamine-induced mucosal contraction. Azelastine could inhibit electrical field stimulation-induced spike mucosal contraction. Moreover, increase in concentration of azelastine had minimal effect on basal tension of nasal mucosa. CONCLUSIONS: The technique in our study is simple and reproducible. Azelastine could inhibit both EFS and methoxamine-induced nasal mucosal contractions in vitro. This study highlights that although azelastine nasal spray is often used in treating allergic rhinitis to improve symptoms, nasal obstruction may be not relieved immediately due to the anti-sympathetic effect of azelastine.
引用
- Cheng LH, Lee JC, Wu PC, et al. Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis. Rhinology. 2019. PMID: 30887967. doi:10.4193/Rhin18.274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。